BY IDA JORGENSEN
-
Eli Lilly overtook Novo Nordisk in the US: Next step is global leadership
US-based Eli Lilly wants build on its strong momentum and outperform Novo Nordisk in the global obesity market, says the company’s executive vice president. Analyst still sees the …
-
Novo Nordisk reorganizes in quest to find its next blockbuster drug
Novo Nordisk transforms technique in very early research study with brand-new company and enhanced use information and expert system.
-
WSA’s new platform took five years to develop – but hearing aid is now constantly online
Jan Makela, Chief Executive Officer of WS Audiology, calls it “a great deal of job” to create the brand-new Widex system, which has actually been 5 years planned.
-
Humanoid helpers are now entering our homes
Join the Future Explored newsletter! Good points on the past, fresh and future of world altering tech It’s 2027. You neutral launched yourself to NEO, the humanoid robot who will be residing with you for the foreseeable future. The robot is designed to lend a hand out with chores and diversified initiatives, and it’s no
-
Japanese Otsuka acquires Swiss biotech startup
Japanese Lundbeck companion Otsuka is putting triple-digit USD millions right into the Swiss biotech start-up as a result of its cancer cells pipe.
-
Investors stoke confidence in obesity drug progress
Market participants and heavyweights like Novo Nordisk are anticipated to reinforce their weight problems profile via purchases, according to market specialists.
-
Will Solana (SOL) Reclaim $180? Key Chart Signals Massive Move
The message Will Solana (SOL) Recover $180? Secret Graph Signals Enormous Relocate showed up initially on Coinpedia Fintech InformationAfter a noteworthy rate decrease in current d…
-
Demant appoints Resmed director as new board member
The brand-new board participant has a lengthy background in the clinical tool sector.
-
Novo Nordisk lowers US price of Wegovy
It belongs to a bigger offensive in the United States market that consists of the launch of an electronic drug store solution.
-
Eli Lilly signs potential billion-dollar deal with biotech startup
With the bargain, Eli Lilly is the most recent amongst pharmaceutical producers to get molecular adhesive. Novo Nordisk is likewise in the area.